CS logo
small CS logo
JR Tokyo General Hospital

Tokyo Shibuya Ku, Japan
General hospital in Shibuya, Tokyo
2 Chome-1-3 Yoyogi, Shibuya City, Tokyo 151-8528

About JR Tokyo General Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Society for Advancement of Coronary Intervention Research
2
Imunon
1
North East Japan Study Group
1
Total Rows: 4

Clinical Trials at JR Tokyo General Hospital


During the past decade, JR Tokyo General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111001100111100Started TrialsCompleted Trails201620172018201900.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
2008-05-01
2016-08-01
Completed
701
Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
2009-04-01
2012-08-01
Unknown status
250
Xience/Promus for Long Coronary Lesion Registry
2010-02-01
2012-12-01
Unknown status
450
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
2012-06-06
2021-02-01
Completed
752
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
2017-01-17
2019-08-12
Completed
663
Japanese Idiopathic Interstitial Pneumonias Registry
2016-12-01
2023-05-01
Active, not recruiting
867
A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
2019-04-16
2022-08-30
Completed
436

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "JR Tokyo General Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 3Boehringer Ingelheim: 3Society forAdvancement ofCoronary InterventionResearch: 2Society forAdvancement ofCoronary InterventionResearch: 2Imunon: 1Imunon: 1North East Japan Study Group: 1North East Japan Study Group: 1

Created with Highcharts 11.1.0Top CollaboratorsBoehringer Ingelheim: 1Boehringer Ingelheim: 1

Clinical Trials Conditions at JR Tokyo General Hospital


According to Clinical.Site data, the most researched conditions in "JR Tokyo General Hospital" are "Lung Diseases, Interstitial" (2 trials), "Hepatocellular Carcinoma" (1 trials), "Idiopathic Interstitial Pneumonia" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Long Coronary Artery Disease" (1 trials). Many other conditions were trialed in "JR Tokyo General Hospital" in a lesser frequency.

Clinical Trials Intervention Types at JR Tokyo General Hospital


Most popular intervention types in "JR Tokyo General Hospital" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nintedanib" (3 trials), "5% Dextrose Solution" (1 trials), "Intracoronary stent implantation" (1 trials), "Placebo" (1 trials) and "TAXUS Liberté paclitaxel-eluting coronary stent system" (1 trials). Other intervention names were less common.

Clinical Trials Genders at JR Tokyo General Hospital


The vast majority of trials in "JR Tokyo General Hospital" are 7 trials for "All" genders.

Clinical Trials Status at JR Tokyo General Hospital


Currently, there are NaN active trials in "JR Tokyo General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in JR Tokyo General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in JR Tokyo General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Unknown status: 2Unknown status: 2Active, not recruiting: 1Active, not recruiting: 1